| Health Care Equipment & Supplies Industry | Healthcare Sector | Dr. Gregory Vizirgianakis CEO | OTCQX Exchange | US58500G1076 ISIN |
| US Country | 37 Employees | - Last Dividend | - Last Split | - IPO Date |
Medinotec Inc. is a pioneering entity in the medical device sector, focusing on the innovation, manufacturing, and distribution of cutting-edge medical tools and solutions. Incorporated in 2021 and headquartered in Johannesburg, South Africa, the company has dedicated its efforts to advancing healthcare through the development of specialized devices aimed at enhancing patient care and treatment outcomes. Medinotec Inc. caters to a broad spectrum of healthcare facilities including hospitals, clinics, and third-party healthcare providers. Additionally, it reaches out to distributors, governmental healthcare programs, and group purchasing organizations. The company's market presence spans both local and international territories, serviced by a robust network of distributors alongside a motivated direct sales force.
These catheters are designed for the dilation of coronary arteries to treat atherosclerotic stenosis in coronary arteries. By offering semi-compliant features, they allow for precise diameter control during the procedure, enhancing safety and efficacy.
Suction dissectors facilitate the removal of tissues or fluids during surgery, improving the precision and cleanliness of the operations. They are particularly useful in surgeries requiring fine dissection and aspiration.
These catheters are utilized in procedures involving the aorta, where they help in delivering oxygenated blood or in dilating the vessel. Their design and functionality are crucial in surgeries addressing aortic diseases, providing life-saving interventions.
Chronic total occlusion catheters are specifically designed to address the challenges of chronic total occlusions in coronary and peripheral arteries. They help in re-establishing blood flow in completely occluded vessels, a vital treatment for patients suffering from severe forms of arterial blockage.
These stents are implanted into the trachea to keep it open in cases of constriction or collapse. Made from silicone, they are flexible and compatible with body tissues, significantly improving the patients' breathing and quality of life.